LANIFIBRANOR-INDUCED IMPROVEMENT OF LIVER AND CARDIOMETABOLIC MARKERS OF NASH IS ASSOCIATED WITH AN INCREASE IN ADIPONECTIN

Gu, LJ; Chen, C; Du, YH; Matye, D; Hasan, MN; Clayton, YD; Friedman, JE; Li, TG

HEPATOLOGY, 2022; 76 (): S771